This trial included 1.8 billion people in the treatment group and 663 million people in the control group, suggests a 69.9% lower death rate for countries that actively used hydroxychloroquine (HCQ) versus those that did not. 

(hydroxychloroquine) Early treatment with hydroxychloroquine: a country-based analysis. https://hcqtrial.com